Biotechnology Stocks I Performance Guide: Arcutis Biotherapeutics, Inc. (ARQT)
ARQT has no dividends.
Table and Chart of ARQT Performance
See what a $1,000 investment in ARQT is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| ARQT Returns | |
|---|---|
| Start Date | Feb-28-2020 |
| Start Price | $26.58 |
| End Date | May-17-2024 |
| End Price | $9.20 |
| # Prices | 52 |
| Min Date | Nov-30-2023 |
| Min Price | $1.84 |
| Max Date | Feb-26-2021 |
| Max Price | $34.17 |
| Total Return | -65.38% |
| Annualized Return | -21.71% |
| Current Value of $1,000 Purchase | $346 |
| Number Returns | 1,326 |
| Average Return | -33.24% |
| Number Profitable Returns | 186 |
| Percent Profitable Returns | 14.03% |
| Number Unprofitable Returns | 1,140 |
| Percent Unprofitable Returns | 85.97% |
| Profitable to Unprofitable Returns Ratio | 0.16 |
| ARQT Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,065,029,000 |
| Beta | 1.182 | Price to Sales | 19.67 |
| Earnings per Share | $-2.7900 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 13.2 |
| PRICE DATA | |
| 52 Week High | $13.17 |
| 52 Week Low | $1.76 |
| Analyst Target Price | $18.83 |
| 50-Day Moving Average | $9.63 |
| 200-Day Moving Average | $6.35 |
| FINANCIAL DATA | |
| Revenue per Share | $1.301 |
| Revenue | $106,394,000 |
| Profit Margin | -204.4% |
| Return on Equity | -119.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
ARQT Compare Returns with S&P 500
ARQT Trendline Chart
ARQT Moving Average Chart
ARQT Stock Return Map - See Patterns of Gains and Losses
ARQT Stock Returns/Purchase Dates